The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0
October 16, 2020
Shockwave Technology to Sonically Bust Calcified Coronary Lesions Shows Safety and Efficacy in U.S. Pivotal IDE Trial
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary…
Read More
Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage closure (LAAC) CLAAS device performed in the U.S. and Prague were presented at 2020 Transcatheter Cardiovascular Therapeutics (TCT) Connect virtual meeting. Two two abstracts were presented by William Gray, M.D., from Lankenau Heart Institute, Wynnewood, Penn., and Vivek Reddy, M.D., from Mount Sinai Hospital in New York. #TCT2020 #TCTconnect
October 16, 2020
Conformal Medical CLAAS LAA Occluder Shows Promising Clinical Results at TCT 2020
October 16, 2020 — Positive clinical data from first-in-human studies of the Conformal Medical left atrial appendage…
Read More
The Abbott Vascular Xience Sierra drug eluting stent (DES). The XIENCE 28 and XIENCE 90 studies presented at TCT 2020 showed the stent can be used safely with only one month of dual antiplatelet therapy (DAPT). #TCT #TCTconnect #TCT2020
October 16, 2020
Shorter DAPT With Xience Stent is Noninferior to Standard DAPT
October 16, 2020 – Results from the XIENCE 90/28 clinical trials have shown that a shorter course of dual-antiplatelet…
Read More
The Abiomed Impella was highlighted in several sessions at the 2020 TCT Connect conference. #TCT #TCT2020 #TCTconnect
October 16, 2020
Restore EF Study Demonstrates Impella Supported High-Risk PCI Improves Left Ventricular Ejection Fraction
October 16, 2020 — The Restore EF Study demonstrates the use of contemporary best practices, including attempting a…
Read More
The Keystone Heart TriGuard 3 (TG3) is a self-stabilizing cerebral embolic deflection filter used in patients undergoing transcatheter aortic valve replacement (TAVR). The device is designed to reduce TAVR complications of cerebral embolization and ischemic stroke. #TCT #TCT2020 #TCTconnect
October 15, 2020
Keystone Heart TAVR Embolic Protection Device Did Not Demonstrate Superiority 
October 15, 2020 – The REFLECT II randomized clinical trial evaluating the safety and efficacy of the Keystone Heart…
Read More
Philip's co-registration technology showing angiography overlaid with iFR in a coronary vessel segment with a system of dots that show regions where the hemodynamic pressure drops occur. This can aid in identifying culprit lesions. #TCT #TCT2020 #TCTconnect
October 15, 2020
DEFINE PCI Study One-year Data Show Potential of Treating Residual Ischemia to Improve Outcomes for Coronary Stenting
October 15, 2020 — The one-year results of the late-breaking DEFINE PCI study showed patients had improved outcomes and…
Read More
GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems, which includes new features based on artificial intelligence (AI) that enable clinicians to acquire faster, more repeatable exams consistently.
October 15, 2020
GE Healthcare Receives FDA Clearance for AI-powered Cardiovascular Ultrasound System
October 13, 2020 — GE Healthcare announced U.S. FDA 510k clearance for its Ultra Edition package on Vivid …
Read More
The Boston Scientific Acurate neo self-expanding TAVR valve (left) did not perform as well clinically as the Medtronic CoreValve Evolut TAVR valve (right) in the SCOPE II trial presented at TCT 2020. #TCT #TCT2020 #TCTconnect
October 15, 2020
Acurate neo TAVR Valve Fails to Meet Noninferiority With Medtronic CoreValve Evolut
October 15, 2020 – The SCOPE II trial comparing the Boston Scientific Acurate neo vs. Medtronic CoreValve Evolut TAVR…
Read More
An illustration showing the MitraClip catheter entering the left atrium through a transseptal puncture. #TCT2020 #TCTconnect
October 15, 2020
Transcatheter Closure of Residual ASD After Transcatheter Mitral Valve Repair Was Not Superior to Medical Therapy
October 15, 2020 – The MITHRAS randomized clinical trial found that interventional closure of an iatrogenic atrial…
Read More
TCT 2020 Late-breaking Study trial Presentations Announced. #TCTconnect #TCT2020 #TCT
October 15, 2020
TCT 2020 Late-breaking Study Presentations Announced
October 15, 2020 — The late-breaking studies are one of the hallmarks of the annual Transcatheter Cardiovascular…
Read More
Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit. Research examines telehealth, healthcare disparities, as well as impacts on interventional cardiology, patient-centered care.
October 14, 2020
Effect of COVID-19 on Cardiology Highlighted in Research at ACC Quality Summit
October 14, 2020 — American College of Cardiology (ACC) Quality Summit virtual meeting Oct. 8-9, 2020, featured several…
Read More
Interventional cardiology and structural heart pioneer Martin Leon, M.D., is the name-sake of the new joint ACC-CRF Center for Cardiovascular Transformation. 
October 14, 2020
ACC and CRF Create the Martin B. Leon Center for Cardiovascular Transformation
October 14, 2020 — The American College of Cardiology (ACC) and the Cardiovascular Research Foundation (CRF) are…
Read More
Medtronic is starting a randomized, head-to-head study comparing the Medtronic CoreValve Evolut Pro and Pro+TAVR Systems against the balloon-expandable Edwards Sapien 3 and Sapien 3 Ultra Transcatheter Heart Valvestwo transcatheter aortic valve replacement (TAVR) systems in patients with severe symptomatic aortic stenosis (ssAS). 
October 14, 2020
Medtronic Launches Head-to-Head TAVR Study Comparing the Corevalve Evolut vs Edwards Sapien in Small Annulus Patients
October 14, 2020 — Medtronic announced it is starting a randomized, head-to-head study comparing two transcatheter…
Read More
COVID-19 Positive STEMI Patients Have Higher Mortality, First data presented at #TCT2020 on COVID heart attack patients.
October 14, 2020
COVID-19 Positive STEMI Patients Have Higher Mortality 
October 14, 2020 – The first outcomes data from the North American COVID-19 ST-Segment Elevation Myocardial Infarction…
Read More
Flexible electronics have been developed to implant in patients to constantly monitor their cardiac condition.
Udi Nussinovitch M.D., Ph.D.
October 09, 2020
What is New in Cardiology? A Review of All Major Emerging Technologies for Heart Diseases
This is an overview of some of the biggest cardiology technology advances. These innovations are covered in more detail…
Read More
The Philips Lumify point-of-care ultrasound (POCUS) system uses an app and a transducer to convert a smartphone into a portable ultrasound system. Philips and GE Healthcare both offer small hand-held systems and are now facing increased competition from new POCUS vendors like Butterfly Network.
Alan Stoddart, Signify Research
October 08, 2020
Point-of-care Ultrasound Sees Rapid Growth Amid COVID-19 and May be Poised for Consumers
For all the changes in medicine there are some things that seem resolutely stable. Chief among these is the idea that…
Read More
October 08, 2020
First Patients Treated with Galaxy Medical Centauri Pulsed Electric Field Cardiac Ablation System
October 8, 2020 — Galaxy Medical, a developer of pulsed electric field (PEF) technology for the treatment of cardiac…
Read More
Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS) technology that can turn a smartphone into a diagnostic imaging system. It offers a new needle guidance app.
October 08, 2020
Butterfly Network Releases New Version of Point-of-Care Ultrasound Platform With Butterfly iQ+
October 8, 2020 – Butterfly Network Inc. is launching its next-generation Butterfly iQ+ point-of-care-ultrasound (POCUS…
Read More
October 08, 2020
Identifying Hubs of Re-entry Driving Persistent Atrial Fibrillation May Improve Treatment
October 8, 2020 – People who suffer from persistent atrial fibrillation in the heart may find relief from a new…
Read More
Siemens Healthineers has introduced a new version of its c.cam dedicated SPECT cardiac nuclear medicine system to the U.S. market. This single-photon emission computed tomography (SPECT) scanner with a reclining patient chair offers nuclear cardiology providers a low total cost of ownership, ease of installation, and a high level of image quality.
October 07, 2020
Siemens Healthineers Debuts New Version of c.cam Cardiac SPECT System
September 30, 2020 — Siemens Healthineers has introduced a new version of its c.cam dedicated cardiac nuclear medicine…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now